News & Media - Page 48 of 49

Mar 12, 2006 | By Gayle Gerling Pettinga | Read Time: < 1 minute | news

Taxotere Approved for Treatment of Advanced Gastric Adenocarcinoma

March 2006 — Taxotere was approved for use in combination with cisplatin and fluorouracil for patients being treated for advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who had not received prior chemotherapy. Reference: “Taxotere Wins FDA Approval for Advanced Gastric Cancer.” Cancer Network, www.cancernetwork.com/view/taxotere-wins-fda-approval-advanced-gastric-cancer

Aug 18, 2004 | By Gayle Gerling Pettinga | Read Time: < 1 minute | news

Taxotere Approved to Treat Another Form of Breast Cancer

August 2004 — Taxotere was approved for use in combination with doxorubicin and cyclophosphamide for the adjuvant treatment of women with operable node-positive breast cancer. Reference: Martins, Ines. “Docetaxel (Taxotere).” Breast Cancer News, 19 Apr. 2016, breastcancer-news.com/docetaxel-taxotere/

Aug 6, 2004 | By Gayle Gerling Pettinga | Read Time: < 1 minute | Dangerous Drugs

National Cancer Institute Study Links Ranitidine To Cancer

2004 — A National Cancer Institute Study in 2004 linked ranitidine to bladder cancer. Reference: “Zantac Lawsuit Leads for Attorneys: Drug Injury.” Broughton Partners, 12 Jan. 2021, https://www.broughtonpartners.com/products/zantac-lawsuit-campaigns-for-attorneys/

May 10, 2004 | By Gayle Gerling Pettinga | Read Time: < 1 minute | news

Taxotere Approved for Use to Treat Type of Prostate Cancer

May 2004 – Taxotere was approved for use in combination with prednisone for the treatment of metastatic, androgen-independent prostate cancer. Reference: Martins, Ines. “Docetaxel.” Prostate Cancer News Today, 11 Mar. 2016, prostatecancernewstoday.com/docetaxel/

Dec 12, 1999 | By Gayle Gerling Pettinga | Read Time: < 1 minute | news

Taxotere Approved for Use as Injection

December 1999 – Taxotere was approved as an injection to treat patients suffering from locally advanced or metastatic non-small cell lung cancer following failure of prior platinum-based chemotherapy. Reference: “FDA Approves New Taxotere® (Docetaxel) Injection Concentrate Formulation – Aug 5, 2010.” Sanofi, www.news.sanofi.us/press-releases?item=118530

Jun 22, 1998 | By Gayle Gerling Pettinga | Read Time: < 1 minute | news

Taxotere Approved for Treatment of Metastatic Breast Cancer

June 1998 – Taxotere was approved for first-line treatment of metastatic breast cancer in subjects whose disease had recurred despite adjuvant therapy. Reference: “Taxotere (Docetaxel).” CenterWatch RSS, www.centerwatch.com/directories/1067-fda-approved-drugs/listing/4266-taxotere-docetaxel

Jun 10, 1997 | By Gayle Gerling Pettinga | Read Time: < 1 minute | Dangerous Drugs

GlaxoKlineSmith Ranitidine Patent Expires

1997 — In 1997, GlaxoKlineSmith’s U.S. patent for ranitidine expired. Competitors were now able to create generic alternatives. Reference: “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.

May 18, 1996 | By Gayle Gerling Pettinga | Read Time: < 1 minute | news

Taxotere Approved by FDA

May 1996 – Taxotere was approved for use by the U.S. Food & Drug Administration. Reference: “Taxotere Gets FDA Approval for Treatment of Advanced Breast Cancer.” Cancer Network, www.cancernetwork.com/view/taxotere-gets-fda-approval-treatment-advanced-breast-cancer

Dec 6, 1988 | By Gayle Gerling Pettinga | Read Time: < 1 minute | Dangerous Drugs

Zantac Experiences Exponential Growth

1988 — In 1988, Zantac became the world’s best selling drug and one of the first drugs to ever top $1 billion in annual sales. Reference: “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.

Jun 22, 1983 | By Gayle Gerling Pettinga | Read Time: < 1 minute | Dangerous Drugs

Zantac Approved by FDA

1983 — Zantac was first approved by the FDA and sold in the U.S. in 1983. Reference: “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.